News

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an uncommon cause of neck pain and radiculopathy that can ...
The remaining PROMs were developed without adequate pilot testing or patient involvement. “In conclusion, this systematic review revealed shortcomings in many of the current PROMs used to assess HRQoL ...
The Menlo Park, California biotech plans to test NVG-2089 in chronic inflammatory demyelinating polyneuropathy (CIDP) – a neurological disorder that causes weakness and impaired feeling in the ...
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...
The compan Immunovant's batoclimab shows strong efficacy in MG & CIDP, but shifts focus to the lead drug IMVT-1402 for these indications to induce deeper, lasting relief. Immunovant and Roivant ...
The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US ...
Heart disease refers to any problem affecting the heart, such as coronary artery disease, arrhythmia, and heart failure. Symptoms and treatments depend on the type of heart disease someone has ...
“I planned to test them for a week, but I noticed the effects much sooner. After 2 days, I felt less stressed (especially at work) and could tell the gummies were working,” she said.
Background: Chronic kidney disease (CKD) is associated with an increased risk of fracture. Decreased bone mass and disruption of microarchitecture occur early in the course of CKD and worsens with ...